Italia markets closed

ILMN Jan 2025 280.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
95,000,00 (0,00%)
Alla chiusura: 11:28AM EDT
Schermo intero
Chiusura precedente95,00
ApertoN/D
Denaro107,00
Lettera116,00
Prezzo d'esercizio280,00
Scadenza2025-01-17
Min-Max giorno95,00 - 95,00
Contratto - Min-MaxN/D
VolumeN/D
Open InterestN/D
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera